Delineation of ligand binding and receptor signaling activities of purified P2Y receptors reconstituted with heterotrimeric G proteins.

Authors:
Bodor ET; Waldo GL; Blaesius R; Harden TK.

Journal:
Purinergic Signal

Publication Year: 2004

DOI:
10.1007/s11302-004-4748-1

PMCID:
PMC2096568

PMID:
18404399

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Purinergic Signal

Abbreviation: Purinergic Signal

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
P2Y<sub>11</sub>/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-…
Klaver D; Thurnher M. (2023) - Transparency Score: 3/6
Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotec…
Fishman P; Stemmer SM; Bareket-Samish A and 2 more (2023) - Transparency Score: 3/6
The P2X7 receptor in mucosal adaptive immunity.
Grassi F; Marino R. (2023) - Transparency Score: 3/6
Burnstock oration - purinergic signalling in kidney transplantation.
Dwyer KM. (2022) - Transparency Score: 3/6
Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmon…
Dales MO; Mitchell C; Gurney AM and 2 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"This work was supported by grants GM38213, HL34322, and HL54889 from the National Institutes of Health and the American Heart Association."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025